160 related articles for article (PubMed ID: 7099168)
1. A postulated mechanism for heparin's potentiation of C1 inhibitor function.
Caughman GB; Boackle RJ; Vesely J
Mol Immunol; 1982 Feb; 19(2):287-95. PubMed ID: 7099168
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
[TBL] [Abstract][Full Text] [Related]
3. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
[TBL] [Abstract][Full Text] [Related]
4. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
Doekes G; van Es LA; Daha MR
Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
[TBL] [Abstract][Full Text] [Related]
5. New insight into the effects of heparinoids on complement inhibition by C1-inhibitor.
Poppelaars F; Damman J; de Vrij EL; Burgerhof JG; Saye J; Daha MR; Leuvenink HG; Uknis ME; Seelen MA
Clin Exp Immunol; 2016 Jun; 184(3):378-88. PubMed ID: 26874675
[TBL] [Abstract][Full Text] [Related]
6. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
Peitsch MC; Kovacsovics TJ; Tschopp J; Isliker H
J Immunol; 1987 Mar; 138(6):1871-6. PubMed ID: 3029223
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.
Fischer MB; Prodeus AP; Nicholson-Weller A; Ma M; Murrow J; Reid RR; Warren HB; Lage AL; Moore FD; Rosen FS; Carroll MC
J Immunol; 1997 Jul; 159(2):976-82. PubMed ID: 9218619
[TBL] [Abstract][Full Text] [Related]
8. Surface-bound capsular polysaccharide of type Ia group B Streptococcus mediates C1 binding and activation of the classic complement pathway.
Levy NJ; Kasper DL
J Immunol; 1986 Jun; 136(11):4157-62. PubMed ID: 3517165
[TBL] [Abstract][Full Text] [Related]
9. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
10. Glycosaminoglycans enhance complement hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions.
Chang NS; Boackle RJ
Mol Immunol; 1986 Aug; 23(8):887-93. PubMed ID: 3796630
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
Webster GF; McArthur WP
Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin on the complement system in vitro.
Hänsch GM; Voigtländer V; Rother U
Int Arch Allergy Appl Immunol; 1980; 61(2):150-8. PubMed ID: 7351347
[TBL] [Abstract][Full Text] [Related]
13. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
14. Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis.
Fukuta D; Miyagawa S; Yamada M; Matsunami K; Kurihara T; Shirasu A; Hattori H; Shirakura R
Xenotransplantation; 2003 Mar; 10(2):132-41. PubMed ID: 12588646
[TBL] [Abstract][Full Text] [Related]
15. Polyphosphate is a novel cofactor for regulation of complement by a serpin, C1 inhibitor.
Wijeyewickrema LC; Lameignere E; Hor L; Duncan RC; Shiba T; Travers RJ; Kapopara PR; Lei V; Smith SA; Kim H; Morrissey JH; Pike RN; Conway EM
Blood; 2016 Sep; 128(13):1766-76. PubMed ID: 27338096
[TBL] [Abstract][Full Text] [Related]
16. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.
Lathem WW; Bergsbaken T; Welch RA
J Exp Med; 2004 Apr; 199(8):1077-87. PubMed ID: 15096536
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of organic solvents on immunity indicators in serum.
Stefanovic J; Starsia Z; Murgasová I; Absolonová O
J Hyg Epidemiol Microbiol Immunol; 1987; 31(1):1-7. PubMed ID: 3571967
[TBL] [Abstract][Full Text] [Related]
19. Activation of the classical pathway of complement by Hageman factor fragment.
Ghebrehiwet B; Silverberg M; Kaplan AP
J Exp Med; 1981 Mar; 153(3):665-76. PubMed ID: 7252410
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
